Offstream
news

---

Changes

1. Morocco is expected to acquire 65 million doses of the vaccine from AstraZeneca and Sinopharm.
   2020-12-26 01:05:11 (First version)
2. Morocco is expected to acquire 65 million vaccine doses from AstraZeneca and Sinopharm.
   (Current version)

---

Related

A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
2021-06-14

The Ghana Health Service says that over 700,000 people in the country has received their first dose of the AstraZeneca vaccine.
2021-04-12

Kazakhstan suspends talks with AstraZeneca for purchasing its vaccine amidst fears of blood clots in many countries.
2021-03-17

The Therapeutic Goods Administration approves the emergency use of the vaccine developed by the University of Oxford and AstraZeneca for people over 18 years of age in Australia.
2021-02-16

Morocco says that its Sinopharm COVID-19 vaccine will be free for all citizens and will be rolled out in the following weeks.
2020-12-8

The Philippines signs its first supply deal for a COVID-19 vaccine with AstraZeneca to obtain 2.6 million doses of vaccines for more than one million people, covering a percent of its population.
2020-11-27

Morocco reports 5,745 new infections and 82 deaths in the past 24 hours, the highest single-day record of both cases and deaths since the pandemic began, bringing the nationwide totals to 235,310 cases and 3,982 deaths.
2020-11-4

AstraZeneca begins Phase III clinical trials of its potential COVID-19 vaccine, AZD1222, which it developed with the University of Oxford, to some 30,000 adults in the United States.
2020-08-31

Prime Minister Scott Morrison announces that his country has signed a deal with the British-Swedish pharmaceutical company AstraZeneca to manufacture a vaccine against COVID-19 that the company is developing with the Oxford Vaccine Group. The vaccine is currently in Phase III efficacy trials and AstraZeneca says it is targeting a formulation of results by the end of the year. Morrison states that the deal also allows citizens to receive immediate and free access to the vaccines, if successful.
2020-08-18